Hanspeter Waldner

Title: The Innovations of Hanspeter Waldner

Introduction

Hanspeter Waldner is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of genetically engineered T cells. His work has the potential to advance therapeutic approaches in immunology.

Latest Patents

Waldner holds a patent for "Genetically engineered T cells having improved persistence in culture." This patent describes a T cell bank comprising genetically engineered T cells that exhibit enhanced characteristics compared to their non-engineered counterparts. These features include enhanced expansion capacity in culture, enhanced proliferation capacity, reduced apoptosis, and enhanced activation frequencies. The genetically engineered T cells may incorporate a mutated gene involved in cell self-renewal, a disrupted gene involved in apoptosis, a disrupted gene involved in the regulation of T cell exhaustion, or a combination of these elements.

Career Highlights

Waldner is associated with Crispr Therapeutics AG, a company at the forefront of gene editing technology. His work at this organization has allowed him to explore innovative solutions in the realm of genetic engineering and cell therapy.

Collaborations

Some of his notable coworkers include Jonathan Alexander Terrett and Demetrios Kalaitzidis. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Hanspeter Waldner's contributions to the field of biotechnology, particularly through his patent on genetically engineered T cells, highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future developments in immunotherapy.